1. Home
  2. HCAT vs BNTC Comparison

HCAT vs BNTC Comparison

Compare HCAT & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCAT
  • BNTC
  • Stock Information
  • Founded
  • HCAT 2008
  • BNTC 1995
  • Country
  • HCAT United States
  • BNTC United States
  • Employees
  • HCAT N/A
  • BNTC N/A
  • Industry
  • HCAT Computer Software: Programming Data Processing
  • BNTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • HCAT Technology
  • BNTC Health Care
  • Exchange
  • HCAT Nasdaq
  • BNTC Nasdaq
  • Market Cap
  • HCAT 318.2M
  • BNTC 339.8M
  • IPO Year
  • HCAT 2019
  • BNTC N/A
  • Fundamental
  • Price
  • HCAT $4.14
  • BNTC $14.97
  • Analyst Decision
  • HCAT Buy
  • BNTC Strong Buy
  • Analyst Count
  • HCAT 11
  • BNTC 7
  • Target Price
  • HCAT $9.27
  • BNTC $24.43
  • AVG Volume (30 Days)
  • HCAT 993.3K
  • BNTC 32.9K
  • Earning Date
  • HCAT 05-08-2025
  • BNTC 05-12-2025
  • Dividend Yield
  • HCAT N/A
  • BNTC N/A
  • EPS Growth
  • HCAT N/A
  • BNTC N/A
  • EPS
  • HCAT N/A
  • BNTC N/A
  • Revenue
  • HCAT $306,584,000.00
  • BNTC N/A
  • Revenue This Year
  • HCAT $11.33
  • BNTC N/A
  • Revenue Next Year
  • HCAT $9.68
  • BNTC N/A
  • P/E Ratio
  • HCAT N/A
  • BNTC N/A
  • Revenue Growth
  • HCAT 3.60
  • BNTC N/A
  • 52 Week Low
  • HCAT $3.76
  • BNTC $4.75
  • 52 Week High
  • HCAT $9.24
  • BNTC $15.29
  • Technical
  • Relative Strength Index (RSI)
  • HCAT 34.22
  • BNTC 70.53
  • Support Level
  • HCAT $3.85
  • BNTC $11.99
  • Resistance Level
  • HCAT $4.64
  • BNTC $13.00
  • Average True Range (ATR)
  • HCAT 0.39
  • BNTC 1.03
  • MACD
  • HCAT -0.01
  • BNTC 0.34
  • Stochastic Oscillator
  • HCAT 28.57
  • BNTC 94.17

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: